Publication | Open Access
Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy
92
Citations
25
References
2018
Year
This study provides Class III evidence that for patients with stage 1 Val30Met TTR-FAP, LTx and tafamidis increase survival.
| Year | Citations | |
|---|---|---|
Page 1
Page 1